Neuropsychiatric Center of Chicago
The Neuropsychiatric Center of Chicago at Hartgrove Behavioral Health System has received the distinct honor by The Joint Commission as the first and currently only hospital in the nation to receive Disease Specific Certification Designation for the treatment of Brain-Based Disorders. Our team of neuroscience experts takes a comprehensive and interdisciplinary approach to the assessment and treatment of brain-based dysfunction. The program challenges traditional viewpoints of mental health disorders by helping patients understand that the origin of their emotions, behaviors, and thoughts begin in the brain. Through the use of neuroimaging, the team is better able to identify areas of the brain that are malfunctioning, and connect them to specific impairments in emotions, behaviors, and thoughts. This re-conceptualization helps to diminish the stigma that is so frequently associated with mental illness. Utilizing cutting-edge technology, the program identifies and addresses the neurobiological origin of emotional and behavioral problems that are commonly associated with disorders such as:
- Traumatic Brain Injuries (TBI) – Mild to Moderate Severity
- Seizure Disorders / Epilepsy
- Patients Exposed to Drugs In-Utero
- Attention Deficit, Hyperactivity Disorders (ADHD)
- Other Physical and Chemical Brain Dysfunctions
- Closed Head and Sports Related Injuries/Concussions
- Treatment-Resistant Depression, Bipolar and Anxiety Disorders
Our team of neuroscientists includes Chief of Neuropsychiatry Teresa Poprawski, MD a Board-Certified Neuropsychiatrist and QEEG Diplomat, one of less than 60 QEEG diplomats in the world. The team is also comprised of a Neuropsychologist, Advanced Practice Nurses, and specialized Social Workers. Taking a collaborative approach to thorough assessment and individualized treatment, the ultimate goal is minimizing medication trials, and yielding more positive outcomes in a shorter period of time. Each expert provides patient-centered assessment, education, and treatment recommendations to be implemented by the clinical team as well as aftercare providers.
The foundation of the Neuropsychiatric Center of Chicago‘s treatment approach is QEEG (Quantitative Electroencephalogram) testing. Rather than relying on patient self-report and behavioral observations, cutting-edge QEEG provides an objective and detailed picture of the brain’s activity. QEEG results provide the treatment team with valuable information regarding the region of the brain that presents with dysfunction, and allows for targeted medication intervention. Much like the electrodes used in an EKG (Electrocardiogram) that tests the electrical activity of your heart, a similar process is used through QEEG with electrodes placed in targeted regions on the patient’s head, measuring electrical activity in the brain. It is through this non-evasive process that the brain dysfunction can best be identified and treated.
Upon completion of QEEG testing, a uniquely tailored neuropsychological evaluation is completed. Neuropsychological evaluation assists with differential diagnosis, as well as identification of impairments in memory, concentration, attention, and executive functioning. Evaluations, combined with QEEG results provide a more accurate clinical picture of each patient, so that treatment recommendations can be made to optimize patient functioning at home, work and school settings.